The Food and Drug Administration (FDA) proposes to amend the sterility test requirements for biological products. This proposed rule is intended to provide manufacturers of biological products greater flexibility and to encourage use of the most appropriate and state-of-the-art test methods for assuring the safety of biological products.
ISPE will be collecting comments for the proposed amendments from interested members. Please submit comments to firstname.lastname@example.org by 25 August 2011.
Direct Access to Quality Manufacturing Experts
Wednesday, 25 May 2016 13.05
Broadening Pharmaceutical Training Footprint in Europe
Tuesday, 24 May 2016 19.05
Quality Manufacturing Leaders Shaping Regulatory & Compliance Landscapes
Monday, 23 May 2016 14.05